Skip to main content
Equibles

Nuveen, LLC

Position in SMMT — Summit Therapeutics Inc.

CIK 1871926 CHARLOTTE, NC
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$4,296,211
-$329,876 QoQ
Shares Held
294,867
+20.9% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 242 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Nuveen, LLC holds $4,966,990,470 across 286 Biotechnology names. SMMT ranks #113 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 2,019,974 $1,259,534,587
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,081,685 $537,305,388
3 EXEL
Exelixis, Inc.
 3,276,984 $178,300,697
4 ALNY
Alnylam Pharmaceuticals, Inc.
 315,630 $95,014,096
5 TGTX
Tg Therapeutics, Inc.
 1,625,876 $89,325,625
6 RVMD
Revolution Medicines, Inc.
 475,231 $89,001,259
7 JAZZ
Jazz Pharmaceuticals plc
 365,405 $88,051,641
8 ROIV
Roivant Sciences Ltd.
 1,970,504 $69,736,134

All Filings in SMMT

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,296,211 294,867
2026-03-31 $4,626,087 243,992
2025-12-31 $4,068,907 232,642
2025-09-30 $4,806,383 232,642
2025-06-30 $3,839,954 180,449
2025-03-31 $4,550,374 235,893